COMPETITIVE AND UNCOMPETITIVE N-METHYL-D-ASPARTATE ANTAGONIST DISCRIMINATIONS IN PIGEONS - CGS-19755 AND PHENCYCLIDINE

被引:21
|
作者
BARON, SP
WOODS, JH
机构
[1] UNIV MICHIGAN, DEPT PSYCHOL, ANN ARBOR, MI 48109 USA
[2] LOUISIANA STATE UNIV, MED CTR, DEPT PHARMACOL & EXPTL THERAPEUT, NEW ORLEANS, LA 70012 USA
关键词
DRUG DISCRIMINATION; NMDA ANTAGONISTS; PHENCYCLIDINE; CGS; 19755; PIGEONS;
D O I
10.1007/BF02245248
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The purpose of the present studies was to examine representative uncompetitive and competitive NMDA antagonists, as well as the glycine/NMDA antagonist, HA 966, in pigeons trained to discriminate either PCP or CGS 19755 from saline. Separate groups of pigeons were trained to discriminate either the uncompetitive, phencyclidine (PCP; 0.32 and 1.0 mg/kg, IM), or the competitive, CGS 19755 (cis-4-phophonomethyl-2-piperidine-carboxylic acid; 1.8 mg/kg, IM), NMDA antagonists from saline. Uncompetitive and competitive NMDA antagonists were examined in generalization studies, as were the racemate and the (+) and (-) stereoisomers of HA 966 (3-amino-1-hydroxypyrrolid-2-one). Dizocilpine (MK 801) was fully generalized to PCP but not to CGS 19755. All competitive NMDA antagonists tested were fully generalized to CGS 19755, but not to PCP. The competitive antagonists, however, produced >50% PCP-appropriate responding. The (+) isomer of HA 966 was fully generalized by three of four pigeons discriminating PCP (1.0 mg/kg) or CCS 19755, whereas the racemate and the (-) isomer produced 40% drug-appropriate responding in either group. Neither NMDA, morphine, nor pentobarbital produced >10% drug-appropriate responding in either discrimination group. The competitive antagonists tended to produce peak drug-appropriate responding at times greater than 60 min after administration, whereas uncompetitive antagonists produced peak drug-appropriate responding at earlier times. HA 966 also had a relatively slow onset of action as compared to PCP. These results suggest that antagonists acting at different modulatory sites of the NMDA receptor complex produce similar, but not identical, discriminative stimuli.
引用
收藏
页码:42 / 51
页数:10
相关论文
共 50 条
  • [21] Modulation of a competitive N-methyl-D-aspartate receptor antagonist binding by zinc oxide
    Terse, PS
    Komiskey, HL
    BRAIN RESEARCH, 1997, 744 (02) : 347 - 350
  • [22] THE EFFECTS OF A COMPETITIVE NMDA RECEPTOR ANTAGONIST (CGS-19755) ON CEREBRAL BLOOD-FLOW AND PH IN FOCAL ISCHEMIA
    TAKIZAWA, S
    HOGAN, M
    HAKIM, AM
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1991, 11 (05): : 786 - 793
  • [23] Attenuation of hyperalgesia by LY235959, a competitive N-methyl-D-aspartate receptor antagonist
    Davis, AM
    Inturrisi, CE
    BRAIN RESEARCH, 2001, 894 (01) : 150 - 153
  • [24] Influence of subchronic manganese sulfate on binding of a competitive N-methyl-D-aspartate receptor antagonist
    Wu, Q
    Komiskey, HL
    Mbawuike, P
    Childress, V
    FASEB JOURNAL, 2002, 16 (05): : A951 - A951
  • [25] BEHAVIORAL PHARMACOLOGY OF NPC-17742, A COMPETITIVE N-METHYL-D-ASPARTATE (NMDA) ANTAGONIST
    WILLETTS, J
    CLISSOLD, DB
    HARTMAN, TL
    BRANDSGAARD, RR
    HAMILTON, GS
    FERKANY, JW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 265 (03): : 1055 - 1062
  • [26] DRUG DISCRIMINATION BASED ON THE COMPETITIVE N-METHYL-D-ASPARTATE ANTAGONIST, NPC-12626
    WILLETTS, J
    BOBELIS, DJ
    BALSTER, RL
    PSYCHOPHARMACOLOGY, 1989, 99 (04) : 458 - 462
  • [27] THE ANTIPARKINSONIAN AGENT BUDIPINE IS AN N-METHYL-D-ASPARTATE ANTAGONIST
    KLOCKGETHER, T
    JACOBSEN, P
    LOSCHMANN, PA
    TURSKI, L
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1993, 5 (02) : 101 - 106
  • [28] Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: Systemic manipulation of central glycine sites
    Campbell, CM
    Butelman, ER
    Woods, JH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 289 (01): : 521 - 527
  • [29] Methadone: opioid, N-methyl-D-aspartate antagonist or both?
    Oxenham, D
    Farrer, K
    PALLIATIVE MEDICINE, 1998, 12 (04) : 302 - 302
  • [30] Dextropropoxyphene acts as a noncompetitive N-methyl-D-aspartate antagonist
    Ebert, B
    Andersen, S
    Hjeds, H
    Dickenson, AH
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1998, 15 (05) : 269 - 274